Cite

    Mckie, J., Qureshi, S., Iatridis, J., Egorova, N., Cho, S., & Hecht, A. (2014). trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory?. Global spine journal, 4, 071–076. http://access.bl.uk/ark:/81055/vdc_100168568068.0x00000f